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ABSTRACT
Introduction. Midline orofacial defects bear a high degree of morbidity for 
the affected individual, often associated with retardation in neonatal develop-
ment and the need for surgical intervention. The etiology of the deformities, 
despite their high prevalence, remains, however, largely unknown. We report 
on the evaluation and quantification of proliferative and inflammatory mark-
ers in the cleft affected soft palate.
Material and methods. This study included soft palate samples of eight cleft 
lip and palate affected individuals and a control group of six soft tissue speci-
mens obtained during correctional surgery of hyperdentia. All samples were 
processed via immunohistochemistry for marker EGFR, NF-κB, Ki-67, Ma-1. 
The results were evaluated semi-quantitatively and statistically analysed by 
IBM SPSS 25.0. 
Results. Histopathological signs of inflammatory changes were continu-
ous in cleft affected specimen. The quantitative distribution of the markers 
in the cleft affected group displayed a significant correlation between EGFR, 
Ki-67 and NF-κB (p< 0.05), along with a correlation among Ki-67 and NF-κB 
(p< 0.05). Immunoreactive structures in control group showed lower numbers 
in all evaluated specimen. A statistical significance between cleft affected and 
non-cleft tissue was observed in EGFR and Ma-1 (p< 0.05).
Conclusion. Results are suggestive of a tissue phenotype modification in cleft 
affected palate. Observation of distribution and statistical correlation hint 
towards the involvement of epithelial growth inducer EGFR and inflamma-
tory/proliferative marker in epithelial changes.
Keywords: cleft palate; growth factor; inflammation; proliferation
EGFR, Ki-67, NF-κB, Ma-1 in cleft soft palate
J. Tellermann, S. C. Reiser, M. Pilmane
Papers on Anthropology XXVIII/1, 2019, pp. 126–139
https://doi.org/10.12697/poa.2019.28.1.10
    EGFR, Ki-67, NF-κB, Ma-1 in cleft soft palate  |  127
INTRODUCTION 
As of today, cleft  lip and palate (CLP) are among the most common congeni-
tal orofacial abnormalities in the world. Patients oft en suff er from great dis-
comfort during speech, swallowing and normal feeding [1]. While reports on 
incidence vary based on ethnicity and socioeconomic status, the prevalence 
among European-derived populations shows a rate of 1 in 1000 live births 
[2]. A similar account of aff ected individuals has been reported in Latvia [3]. 
 Heterogeneous in nature, the etiology of CLP is believed to be the result of 
multiple genetic and environmental insults [4]. Th e process of palatogenesis 
is initiated at embryonic week 5. Medial nasal processes merge, forming the 
primary palate, lip and anterior incisors. Events during the secondary palate 
development span the outgrowth of palatal shelfs (PS) and vertical reposition-
ing with the subsequent elevation of palate. Complete fusion along midline at 
week 12 is achieved by approximation of PS medial edge epithelial (MEE) cells 
and formation of medial epithelial seam (MES) [5]. 
Although resolution of MES is widely accepted, its underlying mechanism 
is still subject to controversy. Th eories currently proposed by the scientifi c 
community include cell mediated death, the migration of cells towards nasal or 
oral epithelium and epithelial-mesenchymal transition [6]. Disruptive events 
during any step of palatogenesis but prominently during midline fusion, PS 
formation or elevation bear potential risk for an isolated defect in cleft  palate 
or combined cleft  palate/lip defects. A great number of genes is involved in 
the proliferative phases of embryonic development. Coordinated events among 
spatial and temporal developmental factors are crucial. While growth factors 
are common inductors of proliferation, cytokines induced by infl ammatory 
cells are deemed to be determinative in proliferative events and indicative of 
embryopathic stress [7].
Th e epidermal growth factor (EGF) belongs to the fi rst group of growth 
factors identifi ed [8]. Consisting of 53 amino acids [9] and characterized by 
the ability to promote cell proliferation, growth, diff erentiation and inhibition 
of apoptosis, EGF has eff ects on epithelial, mesenchymal and tumour cells [10, 
11, 12]. Tsang et al. (2003) have described the expression of EGF in wound 
healing, aff ecting fi broblast motility and granulation tissue formation [13]. As 
a prototypical ligand, EGF activates EGF receptors (EGFR). EGFR is a trans-
membrane tyrosine kinase receptor and dimerization can activate downstream 
signalling pathways including Janus kinase/signal transducer and activator of 
transcription pathways, mitogen-activated protein kinase and phosphatidylin-
ositol 3-kinase pathways [14]. 
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In the developing palate, EGF and EGFR are mainly expressed in the pro-
liferating MEE of developing palates. Exogenous EGF leads to correction to 
persistent activation of the EGF signalling pathway, resulting in excess prolif-
eration of the MEE cells and prevention of palatal fusion [10]. 
First described in 1983 [15], the antigen Ki-67 has been an important 
marker in determining the growth fraction of a given cell population. Pre-
sent in cell nucleus at all stages of cell cycle (G1, S, G2, M), the marker is not 
expressed in quiescent G0 cells or cells about to enter the G phase [16]. Th e 
role of Ki-67 in human embryonal palatogenesis has not been subject to exten-
sive research [17]. A small number of studies performed on human foetuses 
state that tissue proliferation gradually decreases towards the end of palatal 
fusion, with Vukojevic et al. (2012) describing peak intensity during the 6th 
developmental week [17, 18]. Insults during any stage of proliferative phase are 
expected to be a contributory factor towards facial dysmorphia [19]. 
Nuclear factor-kB (NF-κB) represents a family of inducible transcription 
factors (TF) most prominently known for their involvement in proinfl amma-
tory settings, immune response, tissue proliferation and apoptosis [19]. How-
ever, the specifi c biological eff ect of NF-κB induced TFs appears to vary in 
the context of diff erent cell types and tissue structures. While NF-κB-induced 
genes cause inhibition of growth in keratinocytes, they favour proliferation in 
fi broblasts. Th e marked diff erentiation in eff ects highlights the potential role 
of NF-κB in epidermal and dermal cells [20]. Observation of spatiotemporal 
expression of NF-κB in embryogenesis of mice noted the fi rst appearance of 
NF-κB in embryonic day 12.5, markedly in the embryonic brain and thymus. 
Th e study concluded that NF-κB expression is limited to late stages of mam-
malian development [21]. Th e signifi cance of the functional role of NF-κB in 
embryonic development became evident in a study of knockout mice which 
lacked key components of NF-κB pathway and displayed high rates of embry-
onic lethality [22]. 
Macrophages are innate immune cells displaying functional heterogeneity 
[23]. Tissue macrophages or monocyte-derived recruited cells in the infl amma-
tion process produce host protection by phagocytosis and cytokine secretion 
[24]. Macrophages can be classifi ed as classically activated macrophages (M1) 
or alternatively activated macrophages(M2). M1 macrophages are character-
ized by their pro-infl ammatory phenotype [25]. 
Th e main stimuli for M1 macrophages are interferon-γ, lipopolysaccharide 
and granulocyte macrophage colony-stimulating factor [26, 27]. Reported 
features of M1 macrophages include antigen presentation, the production of 
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interleukin (Il)-1 beta, Il-6, IL-12, Il-18, IL-23, tumour necrosis factor-alpha 
and the production of nitric oxide and reactive oxygen intermediates [28, 29]. 
Activation of M1 macrophages can cause chronic infl ammation and tissue 
damage [30].
Th e aim of this study was the research of cleft  aff ected palate in infants with 
regard to appearance of infl ammatory factors, and distribution of growth and 
proliferative tissue factors.
MATERIAL AND METHODS 
Th e research included eight CLP aff ected patients ranging in age from 3 months 
to 36 months. Five patients were aff ected by unilateral CLP and three patients 
by bilateral CLP. Tissue samples of soft  palate were obtained during surgical 
correction of the cleft  in the Cleft  Lip and Palate Centre at the Institute of Stom-
atology of Riga Stradiņš University. Th e control group included six  samples of 
soft  tissues obtained during surgery correcting the state of hyperdentia. Th ere 
were no associations with CLP, infl ammation or any other  pathology. Th e con-
trol group participants were aged from 6 to 15 years. 
Th e study was independently reviewed and approved by the local Ethical 
Committee of Riga Stradiņš University (2003; 2013), and written informed 
consent was obtained from all parents aft er explanation of the nature of this 
study.
Tissue samples were fi xed for a day in a mixture of 2% formaldehyde and 
0.2% picric acid in 0.1 M phosphate buff er (pH 7.2). Following, they were 
rinsed in thyroid buff er, containing 10% saccharose for 12 hours, then the sam-
ples were embedded into paraffi  n. 3 micrometre thick sections were cut and 
coloured with hematoxylin and eosin (H&E) for subsequent evaluation.
HiDef Detection HRP Polymer system (Cell MARQUE) was used to detect 
EGFR (code sc-71034, mouse monoclonal antibody, working dilution 1:100, 
Santa Cruze Biotechnology, USA), Ki-67 (code 1508202A, rabbit monoclonal 
antibody, working dilution 1:100, Sigma-Aldrich, US), NF-κB (code ab7971, 
rabbit polyclonal antibody, working dilution: 1:100, Abcam, UK), Ma-1 (code 
ab9675, rabbit polyclonal antibody, working dilution 1:100, Abcam, UK).
Th e number of immunopositive structures was graded semi-quantitatively. 
Th e scale from “0” to “+ + +” was used as following: “0“ – no immunoreactive 
structures seen in the visual fi eld, “0/+” – occasional immunoreactive struc-
tures seen in the visual fi eld, “+” – few immunoreactive structures seen in the 
visual fi eld, , “++” – a moderate number of immunoreactive structures seen 
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in the visual fi eld, “+++” – numerous immunoreactive structures seen in the 
visual fi eld [31]. 
Th e images of specimens were captured by using a Leica camera model 
DFC 450, and image processing was realized using Image Pro Plus 6.0 soft ware 
(Media Cybernetics, Silver Spring, Maryland, USA).
Statistical analysis was performed using IBM SPSS version 25.0. Th e results 
included calculation of Spearman’s rank correlation coeffi  cient (rs); nonpara-
metric Mann-Whitney U test was used to compare both study groups. Statisti-
cal signifi cance was assumed if p < 0.05.
RESULTS 
Routinely stained slides displayed mainly parakeratotic invaginated epithelium 
into underlying connective tissue, with basal cell proliferation and patchy dis-
tribution of thickened basement membrane. Superfi cial epithelial cells showed 
varying degrees of vacuolization (Fig.1). Underlying subepithelium demon-
strated consistent infl ammatory infi ltrate with extension of lymphocytes into 
epithelial layer, while connective tissue showed macrophage predominance 
(Fig. 2). Sclerotic changes of blood vessels, neoangiogenesis and granulation 
tissue were detected. 
Figure 1. Perinuclear vacuolization and 
proliferating basal epitheliocytes in cleft af-
fected tissue of soft palate. H&E, ×200.
Figure 2. Invaginations of epithelium into 
underlying connective tissue, proliferat-
ing basal epitheliocytes and intraepithelial 
infl ammatory cells in cleft aff ected tissue of 
soft palate. H&E, ×100. 
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Table 1. Relative number of tissue factor-containing positive structures in cleft lip palate 
aff ected specimen. 
NF-κB
Nr. Gender Age (Months ) EGFR Ki-67 Ep Subep Ma-1
1. Male 3 +++ +++ + ++ ++ *
2. Male 4 +++ ++ +  +++ ++ 
3. Male 4.5 + 0/+ P 0 0/+ ++
4. Male 8 +++ ++ 0/+  ++ ++ 
5. Male 9 + 0 +  + + *
6. Male 10 + 0 0/+  0/+ ++ 
7. Male 10 X X X X + *
8. Male 36 ++ + P 0  + ++
X= no evaluation possible due to insufficient tissue material; P = patchy distribution; * other 
cells (lymphocytes, fibroblasts)
Table 2. Relative number of tissue factor-containing structures in control group.
Nr. Gender Diagnosis Ki-67 NFKB Ma-1 EGFR
1. Male Hyperdentia 0 + 0/+ 0
2. Female Hyperdentia 0 + 0/+ 0/+
3. Female Hyperdentia 0 X 0/+ +
4. Male Hyperdentia + X 0/+ 0/+
5. Female Hyperdentia 0/+ + + ++
6. Female Hyperdentia 0 X 0/+ +
X = insufficient tissue material
EGFR
Expression of EGFR in the epithelium was detected in seven specimens (out of 
eight). EGFR positive cells in the epithelium ranged from few (+) to numerous 
(+++) (Fig. 3).
A statistically signifi cant correlation was observed between EGFR and Ki-67 
positive stained cells (rs=0.943; p< 0.05), as well as NFKB (rs=0.912; p< 0.05). 
Overall, the number of EGFR positive cells was lower in control specimens, 
varying from no positive (0) to moderate (++) positive cells (Fig. 4). Th e dif-
ference of EGFR positive cells was statistically signifi cant (z=–2.150, p=0.032) 
when the CLP group and the control group were compared.
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Figure 3. Numerous EGFR positive epithe-
liocytes in tissue of cleft aff ected soft palate. 
EGFR Immunohistochemistry (IHC), ×200. 
Figure 4. Few EGFR positive epitheliocytes in 
control specimen. EGFR IHC, ×250. 
Ki -67
Ki-67 appearance was variable. While four samples displayed a moderate (++) 
number of positive cells, sporadic patchy positive cell clusters were found in 
two specimens. Absence of any Ki-67 positivity was seen in the remaining two 
samples. 
Prominent expression of Ki-67 showed limitation towards basal and supra-
basal epithelial cell layer with marked absence in superfi cial layers (Fig. 5).
Th e correlation between Ki-67 and NF-κB showed statistical signifi cance 
(rs=0.794; p< 0.05). 
Th e control group showed occasional (0/+) to few (+) positive tissue struc-
tures, with a lower number of overall positively stained cells compared to CLP 
aff ected samples (Fig. 6).
Figure 5. Moderate Ki-67 immunoreactive 
cells with limitation towards basal and su-
prabasal epithelial layers in cleft aff ected 
soft palate. Ki-67 IHC, ×250. 
Figure 6. Absence of Ki-67 positive cells in 
control specimen. Ki-67 IHC, ×200. 
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Ma-1 
Ma-1-positive cells ranged from few 
(+) to moderate (++) (Fig.7). Ma-
1-positive cells in the connective tis-
sue included macrophages, lympho-
cytes and fi broblasts in three cases. 
Th e control group samples showed 
mainly an occasional (0/+) number 
of Ma-1-positive cells. Comparison 
of the number of Ma-1-positive cells 
of the CLP aff ected group to the con-
trol group showed statistical signi-
fi cance (z=–3.091, p=0.002).
NF-κB
NF-κB stained tissue samples demonstrated a continuous expression of positive 
structures, ranging from few (+) to moderate (++) (Fig. 8). Sporadic appear-
ance of positive intraepithelial lymphocytes with abundantly stained subepi-
thelial infl ammatory infi ltrate was presented in the majority of samples. Th e 
control group showed the presence of few (+) positive structures in all samples 
(Fig. 9).
Figure 8. Moderate number of NF-κB posi-
tive cells in cleft palate specimen, cells are 
largely lymphocytes plasma cells, most con-
centrated in between epithelial folds. NFKB 
IHC, ×200. 
Figure 9. Few NF-κB immunoreative struc-
tures in control specimen, occasional pro-
nounced intraepithelial lymphocytes. NFKB 
IHC, × 250. 
Figure 7. Moderate number of Ma-1 positive 
cells in the connective tissue of cleft aff ected 
soft palate. Ma-1 IHC, ×400. 
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DISCUSSION 
Th e histological examination and immunohistological reports of cleft  aff ected 
soft  palate tissue proposes a rare entity. Th e obtained histological data displayed 
consistent mild to moderate chronic infl ammatory changes in all cleft  aff ected 
individuals. Considering the abnormal anatomical confi guration of cleft  soft  
palate, persistent mechanical stress may propose a stimulation for subsequent 
soft  tissue infl ammation. Th e observance of palatal ulceration in CLP aff ected 
infants through tongue motor activity largely supports this hypothesis [32]. 
An isolated report on the histological evaluation of cleft  palate demonstrated 
similar fi ndings of infl ammatory infi ltrate congruent to our observation [33]. 
Infl ammatory changes proposed major diff erence compared to non-cleft  sub-
jects. In evaluation of proliferative marker Ki-67, there seemed to be no dis-
turbances in spatial distribution comparable to our observation; proliferative 
activity in normal mucosa appears to be limited to basal and suprabasal cell 
layers [34]. However, the signifi cantly higher number of Ki-67 immunoreac-
tive cells in cleft  individuals compared to the control group remains suggestive 
of the intensifi cation of proliferative changes in CLP aff ected epithelium. As 
data shows a correlation between Ki-67 and NF-κB, one can assume that Ki-67 
positive cellular proliferation is induced by NF-κB. Yan et al. (2014) proposed 
a model that linked epidermal hyperproliferation in psoriasis to induction of 
NF-κB [35]. It remains to be investigated if the model is transferable to oral 
mucosa; our correlation stands as a unique observance so far. Our work is 
implicative of a correlation between infl ammation and epidermal prolife ration. 
It is, however, of diff erent nature than the ones which have been described 
before. 
Early works on oral mucosa proliferation propose an inverse relationship 
between intensity of infl ammation and proliferation of epithelial cells [36]. 
A report on radicular cyst even noted a higher Ki-67 epithelial expression in 
absence of intense infl ammatory infi ltrate [37]. 
We, however, cannot currently confi rm that assumption, as our results sug-
gest a positive correlation between the infl ammatory marker NF-κB and Ki-67. 
Fernandez et al. (2017) reported the presence of EGFR in normal oral 
mucosa, indicative of the proliferation of epithelial cells. Receptors were found 
to be not only limited to basal stratum cells but were also expressed by supra-
basal cells [38]. Similar fi ndings regarding the distribution of EGFR immuno-
reactive epithelial cells were observed in soft  tissues of the control group 
and in CLP aff ected tissues in our patients. Apart from EGFRs role in tissue 
homeo stasis, aberrant receptor activation is aff ecting carcinogenesis,  including 
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 carcinogenesis of head and neck squamous cell carcinomas [39]. Increased pro-
liferation of epithelial cells has also been observed in hyperproliferative skin 
diseases such as psoriasis vulgaris and seborrheic keratosis where upregula-
tion of EGFR or its ligands has been described [40]. Th erefore, we can assume 
that an overall increase in numbers of EGFR, as observed in CLP aff ected tis-
sue, might demonstrate increased proliferation in those epithelia. Th is could 
be indicative of the phenotypical changes observed in the epithelium of CLP 
aff ected soft  palate tissue. Identifi cation of EGFR in repairing burn wound epi-
thelial margins suggests that the presence of EGFR is a common denominator 
in the wound healing process aft er burn injury [41]. When a mouse spontane-
ous colitis model was used, mice with defective EGFR activity were more sus-
ceptible to experimental colitis [42]. CLP aff ected tissues demonstrated higher 
numbers regarding the presence of EGFR immunoreactive epithelial cells and 
Ma-1-positive cells, mainly macrophages. Lymphocytes and fi broblasts have 
also been noted in subepithelial connective tissue. Observation of mainly 
Ma-1-positive macrophages might be an indicator of persistent infl ammatory 
changes observed in CLP aff ected tissues. Th e M1 macrophages were character-
ized by their ability to produce a wide range of pro-infl ammatory cytokines and 
their microbiocidal capacity [28]. Also, the enhancement of NF-κB-dependent 
gene expression was seen in the classic activation of macrophages [43]. 
CONCLUSION
CLP aff ected palate shows variations of epithelium basal part probably due to 
the tissue phenotype modifi cation with involvement of the epithelial growth 
inducer EGFR and proliferation marker Ki-67. Induction by infl ammation was 
proved by correlation between Ki67 and infl ammation/proliferation marker 
NF-κB, and pro-infl ammatory macrophages activator Ma-1 might also modify 
the epithelium in the cleft  aff ected palate.
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